MS-based metabolic profiling in serum for bipolar disorder

Area of Science:

• Psychiatry
• Metabolomics
• Biomarker Discovery

Background:

• Bipolar disorder (BD) diagnosis relies on subjective assessments, often causing delays and treatment inaccuracies.
• Objective biomarkers are needed to improve diagnostic accuracy and enable early intervention for BD.
• This study investigated serum metabolomic profiles in BD patients to find potential biomarkers.

Purpose of the Study:

• To analyze serum metabolomic profiles of bipolar disorder (BD) patients in manic and euthymic states.
• To identify potential diagnostic and predictive biomarkers for BD.
• To explore the role of lipid metabolism and mitochondrial pathways in BD pathophysiology.

Main Methods:

• Serum samples were collected from 33 manic BD patients, 25 euthymic BD patients, and 40 healthy controls.
• High-resolution liquid chromatography-mass spectrometry was used for metabolomic profiling.
• Statistical analyses included univariate statistics, logistic regression, and pathway enrichment.

Main Results:

• Significant alterations in lipid metabolites, including fatty acid amides and phosphatidylcholine derivatives, were observed in BD patients compared to controls.
• Oleamide and 2-arachidonoylglycerol were associated with the euthymic state.
• Metabolic differences were noted between manic and euthymic states, indicating mood-state influence.

Conclusions:

• Exploratory metabolomics revealed subtle metabolic alterations in BD, emphasizing lipid metabolism and mitochondrial function.
• Findings suggest mood state influences metabolic profiles in BD.
• Further validation in larger, longitudinal cohorts is needed to confirm these preliminary results.